Cargando…
Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462989/ http://dx.doi.org/10.1007/s00125-011-2215-4 |
| _version_ | 1782245236242644992 |
|---|---|
| author | Miao, Y. Dobre, D. Lambers Heerspink, H. J. Brenner, B. M. Cooper, M. E. Parving, H.-H. Shahinfar, S. Grobbee, D. de Zeeuw, D. |
| author_facet | Miao, Y. Dobre, D. Lambers Heerspink, H. J. Brenner, B. M. Cooper, M. E. Parving, H.-H. Shahinfar, S. Grobbee, D. de Zeeuw, D. |
| author_sort | Miao, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3462989 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Springer-Verlag |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34629892012-10-03 Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial Miao, Y. Dobre, D. Lambers Heerspink, H. J. Brenner, B. M. Cooper, M. E. Parving, H.-H. Shahinfar, S. Grobbee, D. de Zeeuw, D. Diabetologia Erratum Springer-Verlag 2011-06-07 2011-08 /pmc/articles/PMC3462989/ http://dx.doi.org/10.1007/s00125-011-2215-4 Text en © Springer-Verlag 2011 |
| spellingShingle | Erratum Miao, Y. Dobre, D. Lambers Heerspink, H. J. Brenner, B. M. Cooper, M. E. Parving, H.-H. Shahinfar, S. Grobbee, D. de Zeeuw, D. Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title_full | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title_fullStr | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title_full_unstemmed | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title_short | Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial |
| title_sort | erratum to: increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in niddm with the angiotensin ii antagonist losartan (renaal) trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462989/ http://dx.doi.org/10.1007/s00125-011-2215-4 |
| work_keys_str_mv | AT miaoy erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT dobred erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT lambersheerspinkhj erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT brennerbm erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT cooperme erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT parvinghh erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT shahinfars erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT grobbeed erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial AT dezeeuwd erratumtoincreasedserumpotassiumaffectsrenaloutcomesaposthocanalysisofthereductionofendpointsinniddmwiththeangiotensiniiantagonistlosartanrenaaltrial |